Supporting information for design, synthesis, anti-tumor activity and mechanism of novel PROTACs as degraders of PD-Ll and inhibitors of PD-1/PD-L1 interaction

Published: 7 March 2024| Version 1 | DOI: 10.17632/xgww25d52t.1
Contributors:
feng zhang,

Description

Supporting information for design, synthesis, anti-tumor activity and mechanism of novel PROTACs as degraders of PD-Ll and inhibitors of PD-1/PD-L1 interaction

Files

Institutions

Zhejiang University of Technology

Categories

Pharmacy, Pharmaceutical Chemistry, Drug Synthesis

Funding

National Natural Science Foundation of China-China Academy of General Technology Joint Fund for Basic Research

21877101, 22177105

Zhejiang Provincial Key Discipline of Chemical Biology.

Licence